Nell’ultimo workshop “Startup e Grande impresa” sono stati messi a confronto due modalità di fare impresa, il modello delle #startup e quello delle grandi #corporate. Le studentesse e gli studenti presenti hanno avuto la possibilità di chiedere che cosa le grandi aziende si aspettano da parte di un neolaureato e quali sono invece i percorsi da seguire per far partire un progetto di ricerca in proprio. Da un approccio flessibile nelle specializzazioni tipico delle startup, dove ci sono meno risorse da investire, staff e struttura ridotti al minimo, a grandi imprese con aree interne ben strutturate. Ma anche incubatori di impresa, luoghi dove convivono progetti di ricerca pubblici e aziendali. Sono stati molti gli spunti emersi e i consigli professionali forniti da Andrea Paolini, Coordinatore Area Formazione di Federchimica Assobiotec e Direttore Generale della Fondazione Toscana Life Sciences, Giacomo Ghilardi, COO & Co-Founder di BGreen Technologies, Beatrice Riva, Co-founder e CEO di ChemiCare | It's a rare thing to care, Sonia Maffina, Sr HR Business Partner & Employee Relations Lead di AstraZeneca e Vincenzo Jandoli, Partner dello Studio Legale Lexsential. L’evento, promosso da Assobiotec, in collaborazione con Edra S.p.A., ITTBioMed e la media partnership di Sanità33, è ora in corso all’Auditorium dell’Ospedale Galeazzi - Sant'Ambrogio, presso il MIND Milano Innovation District. #BIOTECHFUTURE2024 #JOBINBIOTECH Andrea Ludovico Baldessin
ChemiCare | It's a rare thing to care’s Post
More Relevant Posts
-
🌟 Exciting times at the INNOVIT - Italian Innovation and Culture Hub acceleration program for startups and scale-ups in Life Sciences & Digital Health in San Francisco! Attending this program has been an incredible journey, strengthening the bond between the Italian ecosystem and Silicon Valley, the global heart of innovation. 🚀 The connections we've established with local investors and leading pharma companies have been invaluable, propelling our company forward. 🤝 The collaborative spirit and shared experiences have created a supportive community that will continue to thrive beyond this program. Thanks to the entire INNOVIT team for organizing such experience. #LifeSciences #Innovation #SiliconValley #Startups #ScaleUps #Networking #SanFrancisco #ItalianEcosystem
-
-
-
-
-
1
-
-
ChemiCare desk is ready in INNOVIT - Italian Innovation and Culture Hub, San Francisco. Beatrice Riva Luigi Azzarone
-
-
🌎 Few days missing for our participation in the upcoming acceleration program starting on June 10th in San Francisco, organized by INNOVIT - Italian Innovation and Culture Hub. 🚀 This is a fantastic opportunity for us to promote growth and collaboration. We'll be engaging in intensive workshops, benefiting from tailored mentoring, and taking advantage of networking opportunities right in the heart of Silicon Valley. Stay tuned for updates! 🚀 #LifeSciences #Innovation #Growth #Collaboration #Workshops #Mentoring #Networking #SiliconValley #DemoDay #Healthcare #Startups
-
-
👇👇
Welcome to our upcoming cohort focused on #LifeSciences and #DigitalHealth for a 2-week-long #acceleration program starting on June 3rd. This #innovation program is designed to foster #growth and #collaboration, offering immersive #workshops, personalized #mentoring, and invaluable #networking opportunities in the heart of #SiliconValley. The program concludes with #DemoDay on June 13th, where our #startups will #pitch to potential clients, partners, and investors, showcasing advancements in #healthcare. We look forward to seeing you there! Aileens Pharma, AorticLab, BioCompatibility Innovation, BrainDTech, Cellply, Cerebro Startup, ChemiCare | It's a rare thing to care, COMFTECH srl, Develop-Players, Diamante Società Benefit Srl, Drop Digital Health, enGenome, GEK Lab, InSilicoTrials, InSimili, Life Meter srl, Linari Medical, Math Biology , Mediavoice S.r.l., Medics, MEDICUD, MedLea Srl, More Than Access (MTA), React4life, RIC3D Srl, SERVImed Industrial S.p.A., Techinnova S.p.A.
-
-
📆 Today, on Rare Disease Day, we stand united in raising awareness for over 300 million individuals worldwide who bravely face the challenges of living with rare diseases. In ChemiCare, we are committed to making a meaningful impact on the lives of these resilient individuals. 💙 Our daily mission revolves around improving the quality of life for those battling rare diseases. Through innovation, research, and dedicated efforts, we aim to provide support, resources, and hope to those who need it most. #rarediseaseday
-
-
📣 ChemiCare and Bridge4Pharma are joining forces into a partnership to push forward the development of pipeline initiatives. 🤝 Together with this alliance, Bridge4Pharma S.r.l., decided to invest in ChemiCare S.r.l. 🔬 Bridge4Pharma, a company focused on supporting research and development projects and activities based on diagnostic, therapeutic and medical device technologies, will strategically support ChemiCare operations in preclinical and clinical drug development. “Thanks to the collaboration with Bridge4Pharma and it’s consolidated experience in Research and Development, ChemiCare has the objective to rapidly progress its lead molecule CIC-39 to clinical stage. CIC-39 is a small molecule selectively targeting a key mechanism involved in severe and lethal forms of muscular degeneration like Duchenne Muscular Distrophy (DMD) and Tubular Aggregated Myopathies (TAM) for which no effective treatments exist to date. We are confident that this partnership will bring a concrete and solid contribution to our mission.” Beatrice Riva, Co-Founder & CEO, ChemiCare S.r.l. “The collaboration between ChemiCare and Bridge4Pharma will leverage on the respective capabilities and experience to progress an innovative approach that can potentially address unmet medical needs in severe and lethal muscle disorders. We look forward to working jointly to bring this and future programs into the clinics. ” Maurizio F. Mariani, President & CEO, Bridge4Pharma S.r.l.
-
-
🌟 Yesterday our research assistant Luigi Azzarone took the stage as one of the speakers at MIND Education, a program organized by the MIND Milano Innovation District's main partners. The focus was on engaging and motivating the district's future players: the students. 🧭 The primary goal of this meeting was to guide students in their future choices, providing them with a unique journey into the world of research and innovation, with a particular emphasis on pharmaceutical and biomedical fields. 🎙️ The audience, consisting of students from scientific high schools with a biomedical orientation and ITS Mechatronics, had the opportunity to hear valuable testimonies from the realities that animate MIND such as Bio4Dreams. It was a fantastic opportunity to inspire and empower the next generation of innovators.
-
-
🚀 Yesterday our Research Assistant Luigi Azzarone was among the panelists at the “Strengthening life-sciences innovation across Europe” conference organized by the European Innovation Network (EU-IN) and the Health Products Regulatory Authority (HPRA). 🌐 At this dynamic event, developers and regulators joined forces, engaging in insightful dialogue toward the possibilities to catalyze the innovation into impactful pharma and med-tech products. Luigi actively participated in knowledge exchange sessions, delving into Bio4Dreams structure, collaboration, developments, and future challenges. Their commitment to staying at the forefront of regulatory readiness was evident, as they explored expertise and regulatory standards crucial for success in this rapidly evolving landscape, helping ChemiCare to achieve important regulatory milestones.
-
